Latest news
Loading news…
Immune Targeting Systems
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). London, England, United Kingdom Founded 2003 11-50 employees For Profit
Immune Targeting Systems develops synthetic vaccines for mutating viruses, improving the quality of life for those infected by viruses.
Immune Targeting Systems was acquired by Altimmune in 2015.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
2
3 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 9
- Active products
- 10
- Patents granted
- 2
- Trademarks
- 3
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $9M
Company Info
- Founded
- 2003
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- HQ
- London, England, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Feb 17, 2015
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 0
- Trend (90d)
- -1.5
Key People at Immune Targeting Systems
CEO
Financial Control
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Immune Targeting Systems
Loading news…
FAQs about Immune Targeting Systems
People who checked this page also checked these
Browse the full Acquirezy directory.